All Access Articles |
- Enliven Therapeutics Upsized Public Offering Raises $400M | 2026-06-14 | PHARMACEUTICAL
- Enliven Therapeutics Upsized Public Offering at $37.50/sh, Shares Surge 14.3% | 2026-06-13 | PHARMACEUTICAL
- Enliven Therapeutics' ELVN-001 Shows High Response Rates | 2026-06-11 | PHARMACEUTICAL
- Enliven Therapeutics Reports Positive Results for CML Drug | 2024-04-11 | PHARMACEUTICAL